Paradromics
Paradromics, Inc., based in Austin, Texas, is at the forefront of brain-computer interface (BCI) technology, focusing on high-data rate and high-reliability applications aimed at transforming brain health. Founded by CEO Matt Angle, the company blends expertise in neurotechnology, data science, and medical devices to create advanced BCI platforms that promise groundbreaking applications.
The team includes notable figures such as COO James Burrows and CSO Vikash Gilja, contributing their extensive experience to drive the development of innovative neurotech solutions. In 2023, Paradromics received FDA Breakthrough Device Designation for its speech decoding technology, marking a significant milestone in its commitment to advancing healthcare through neurotechnology.
Generated from the website


